Evidence map›Paper›PMID 21725321›Full record

ArticleNature immunology2011

The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes.

Richard N Hanna, Leo M Carlin, Harper G Hubbeling, Dominika Nackiewicz, Angela M Green, Jennifer A Punt, Frederic Geissmann, Catherine C Hedrick

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 366 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
366citing papers in PubMed, 1 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

366 citing papers in PubMed, 1 synthesis or guideline pooled it, 618 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Monocytes in pneumonia: Functional plasticity and innate memory (Review).International journal of molecular medicine · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. S100A8/S100A9 released by CD11bExperimental & molecular medicine · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. NR4A1 limits CD8Research square · 2026
    Article
  18. Article
  19. Review
  20. Review

306 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Richard N HannaDivision of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Leo M Carlin
Harper G Hubbeling
Dominika Nackiewicz
Angela M Green
Jennifer A Punt
Frederic Geissmann
Catherine C Hedrick
La Jolla Institute for Immunology · USHaverford College · USKing's College London · GBUniversity of Łódź · PL

Funding

G2A Receptor in AtherosclerosisR01HL071141 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HEDRICK, CATHERINE C · 2003 to 2011
$3.5M
Sphingolipids &Cardiovascular Disease Type l DiabetesR01HL079621 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HEDRICK, CATHERINE C · 2004 to 2007
$1.6M
Medical Research Council G0900867NHLBI NIH HHS R01 HL071141NHLBI NIH HHS R01 HL079621
6 · The paper itself

Abstract

The transcription factors that regulate differentiation into the monocyte subset in bone marrow have not yet been identified. Here we found that the orphan nuclear receptor NR4A1 controlled the differentiation of Ly6C- monocytes. Ly6C- monocytes, which function in a surveillance role in circulation, were absent from Nr4a1-/- mice. Normal numbers of myeloid progenitor cells were present in Nr4a1-/- mice, which indicated that the defect occurred during later stages of monocyte development. The defect was cell intrinsic, as wild-type mice that received bone marrow from Nr4a1-/- mice developed fewer patrolling monocytes than did recipients of wild-type bone marrow. The Ly6C- monocytes remaining in the bone marrow of Nr4a1-/- mice were arrested in S phase of the cell cycle and underwent apoptosis. Thus, NR4A1 functions as a master regulator of the differentiation and survival of 'patrolling' Ly6C- monocytes.

Indexed as

AnimalsAntigens, LyApoptosisBone MarrowCell CycleCell DifferentiationDNA DamageFlow CytometryMiceMice, Inbred C57BLMice, KnockoutMonocytesNuclear Receptor Subfamily 4, Group A, Member 1Reverse Transcriptase Polymerase Chain ReactionRNA, MessengerSpecific Pathogen-Free OrganismsAntigens, LyLy-6C antigen, mouseNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1RNA, Messenger

Identifiers

PMID21725321
PMCPMC3324395
OpenAlexW2151362823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.